Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
June 20 2024 - 6:24AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2024
Commission File Number: 001-41641
(Translation of registrant’s name into English)
90 Yigal Alon Street
Tel Aviv 67891, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
On June 20, 2024, SHL Telemedicine Ltd. (the “Company”) issued a press release, a copy of which is furnished herewith as Exhibit 99.1. In the press release
the Company confirmed that it is in discussions with Discount Capital Ltd. (“Discount”), the investment arm of Israel Discount Bank, regarding a
possible investment of Discount in the Company’s Israeli activities. At this point, the parties have not yet taken any decision nor entered into any binding obligation with regard to the realization of any such transaction. The Company will provide
further updates as required.
This Form 6-K is incorporated by
reference into the Company's Registration Statement on Form S-8 filed with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.
|
SHL Telemedicine Ltd.
By: /s/ Amir Hai
Amir Hai
Chief Financial Officer
|
June 20, 2024
Exhibit 99.1
Ad hoc announcement pursuant to Art. 53 LR
SHL Telemedicine confirms discussions regarding a possible investment in its Israeli activity
Tel Aviv / Zurich / New
York, June 20, 2024 - SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced
personal telemedicine solutions, has clarified today that it is in discussions with Discount Capital Ltd. the investment arm of Israel Discount Bank, regarding a possible investment relating to SHL’s Israeli activity. At this point, the parties have
not yet taken any decision nor entered into any binding obligation with regard to the realization of such transaction. SHL will further inform the market as required.
About SHL Telemedicine
SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center
services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication
technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and on the Nasdaq Stock Exchange (SHLT, ISIN: US78423T2006, CUSIP: 78423T200).
For more information, please visit our website at www.shl-telemedicine.com.
Contacts
Fabienne Farner, IRF, Phone : +41 43 244 81 42, farner@irf-reputation.ch
Forward-Looking Statements
Some of the information
contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ
materially from those in the forward- looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.
SHL Telemedicine (PK) (USOTC:SMDCF)
Historical Stock Chart
From Jun 2024 to Jul 2024
SHL Telemedicine (PK) (USOTC:SMDCF)
Historical Stock Chart
From Jul 2023 to Jul 2024